45
Participants
Start Date
November 14, 2022
Primary Completion Date
June 16, 2023
Study Completion Date
December 5, 2023
Pilocaine 2% (1.5 ml) and 25 ug fentany
"Patients will be randomly allocated into the study groups according to the list of random numbers. The study groups will be as follows:~* Group P1 (N 15): patients assigned to this group will receive intrathecal 30 mg (1.5 ml) of prilocaine 2% (Takipril, prilocaine hydrochloride 20 mg/mL, hyperbar, Sintetica) + 25 ug fentanyl (0.5 ml).~* Group P2 (N 15): patient assigned to this group will receive intrathecal 40 mg (2 ml) of prilocaine 2% + 25 ug fentanyl (0.5 ml).~* Group P3 (N 15): patient assigned to this group will receive intrathecal 50 mg (2.5 ml) of prilocaine 2% + 25 ug fentanyl (0.5 ml)."
Ahmed Abdalla Mohamed, Cairo
Norhan Abdel Aleem Ali
UNKNOWN
Hagar Hassanein Refaee
UNKNOWN
Ahmed Abdullah Fathi Mohamed Almadawi
UNKNOWN
Cairo University
OTHER